Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia: a Prospective Single Arm Study
Latest Information Update: 24 Jan 2024
At a glance
- Drugs Hetrombopag (Primary) ; Ciclosporin
- Indications Aplastic anaemia
- Focus Therapeutic Use
- 12 Dec 2023 Status changed from not yet recruiting to recruiting.
- 12 Dec 2023 Results (n=28) assessing the efficacy and safety of adding hetrombopag to cyclosporin A in patients with transfusion-dependent non-severe aplastic anemia presented at the 65th American Society of Hematology Annual Meeting and Exposition
- 26 Aug 2021 New trial record